Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns
The devices are being recalled and discontinued after the FDA shared a series of concerns. This is a Class I recall, meaning using this system could result in serious injuries or death.
Perfuze celebrates a ‘major milestone’ for new-look stroke catheter
The Millipede 088 was designed to treat large vessel occlusion stroke patients by “ingesting” the blood clot as opposed to dragging it through the patient’s blood vessels.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Mediterranean diets that include some lean red meat can still boost cardiovascular health
The study's authors focused on blood pressure reductions and arterial stiffness, sharing their findings in Current Developments in Nutrition.
Late-breaking cardiovascular drug trials took center stage at ACC.25
Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.

Autopsies suggest we still have a lot to learn about COVID-19's impact on the heart

Researchers focused on patients who died during the early stages of the pandemic.

Researchers 'really enthusiastic' about potential breakthrough in the treatment of vascular disease

The new treatment, still being tested in mice models, showed potential to help prevent future cardiovascular events in patients with vascular disease.

TEVAR outcomes don't suffer when performed at low-volume hospitals

Thoracic endovascular aortic repair, researchers wrote, "could be safely preformed across a wide range of hospitals regardless of their volume status."

DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin.

DAPT after PCI can stop after 1 month, new research confirms

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients.

Some hospitalized COVID-19 patients may need anticoagulation therapy at discharge

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

Multicenter trial to evaluate IVL treatment for peripheral lesions below the knee

The Disrupt BTK II study will include 250 patients overall.

New study compares polymer and polymer-free drug-eluting stents after 3 years

The analysis included outcomes data from nearly 1,500 PCI patients.

Vascular & Endovascular

Aspiration system for stroke thrombectomy recalled, discontinued after FDA raises concerns

Perfuze celebrates a ‘major milestone’ for new-look stroke catheter

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Mediterranean diets that include some lean red meat can still boost cardiovascular health

Late-breaking cardiovascular drug trials took center stage at ACC.25